Sorafenib Repurposing for Ophthalmic Delivery by Lipid Nanoparticles: A Preliminary Study
Uveal melanoma is the second most common melanoma and the most common intraocular malignant tumour of the eye. Among various treatments currently studied, Sorafenib was also proposed as a promising drug, often administered with other compounds in order to avoid resistance mechanisms. Despite its pro...
Saved in:
Main Authors: | Angela Bonaccorso (Author), Veronica Pepe (Author), Cristina Zappulla (Author), Cinzia Cimino (Author), Angelo Pricoco (Author), Giovanni Puglisi (Author), Francesco Giuliano (Author), Rosario Pignatello (Author), Claudia Carbone (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Essential Oil-Loaded NLC for Potential Intranasal Administration
by: Angela Bonaccorso, et al.
Published: (2021) -
Essential Oils: Pharmaceutical Applications and Encapsulation Strategies into Lipid-Based Delivery Systems
by: Cinzia Cimino, et al.
Published: (2021) -
Fluorescent Nanosystems for Drug Tracking and Theranostics: Recent Applications in the Ocular Field
by: Elide Zingale, et al.
Published: (2022) -
The Development of Lipid-Based Sorafenib Granules to Enhance the Oral Absorption of Sorafenib
by: Jaylen C. Mans, et al.
Published: (2023) -
Ferulic Acid-Loaded Polymeric Nanoparticles for Potential Ocular Delivery
by: Alessia Romeo, et al.
Published: (2021)